Survey explores biosimilars in rheumatology
Managed Healthcare Executive: Rheumatologists still reluctant to switch patients to biosimilars
Gordon Lam, M.D., FACR, Medical Director of Clinical and Translational Research with Atrium Health in Charlotte, NC,?talks with Managed Healthcare Executive about Cardinal Health’s Rheumatology Insights report and why the data shows that many rheumatologists have been slow to move patients from branded biologic products to biosimilars.